Can-Fite BioPharma Ltd.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $5.9M | $20.3M | $4.4M |
| FY2022 | $4.8M | $9.3M | $3.0M |
| FY2023 | $3.7M | $10.0M | $4.3M |
| FY2024 | $3.7M | $9.1M | $4.8M |
| FY2025 | $3.9M | $9.5M | $5.5M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $5.9M | $20.3M | $4.4M |
| FY2022 | $4.8M | $9.3M | $3.0M |
| FY2023 | $3.7M | $10.0M | $4.3M |
| FY2024 | $3.7M | $9.1M | $4.8M |
| FY2025 | $3.9M | $9.5M | $5.5M |